Evidence map›Paper›PMID 34036451›Full record

ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2022

Evaluation of IL-10, IFN-γ, and thiol-disulfide homeostasis in patients with drug-resistant epilepsy.

Mehtap Kocatürk, Adnan Kirmit

Abstract read
PubMed Publisher
In one paragraph

Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Interleukins in Epilepsy: Friend or Foe.Neuroscience bulletin · 2024
    Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Mehtap KocatürkDepartment of Neurology, Balikesir University, Pasakoy, Bigadic yolu üzeri Merkez/Altıeylul/Balikesir, 10145, Balıkesir, Turkey. mehtap-3381@hotmail.com.ORCID http://orcid.org/0000-0003-1831-246X
Adnan KirmitDepartment of Biochemistry, Harran University, Sanlıurfa, Turkey.ORCID https://orcid.org/0000-0003-2799-8416
Balıkesir University · TRHarran University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThis study compared dynamic thiol-disulfide homeostasis (an oxidative stress marker), anti-inflammatory interleukin-10 (IL-10) levels, and proinflammatory interferon gamma (IFN-γ) levels in drug-resistant epilepsy patients with those in patients with well-controlled epilepsy and healthy controls.

methodThis prospective cross-sectional study enrolled 89 people: 27 with drug-resistant epilepsy, 30 with well-controlled epilepsy, and 32 healthy controls matched in demographic characteristics.

resultsThe mean serum IL-10 levels were significantly lower and the mean serum IFN-γ levels significantly higher in the drug-resistant epilepsy patients compared to the well-controlled epilepsy and healthy control groups. The mean serum native thiol (SH) and total thiol (TT) levels were significantly lower, and the disulfide (SS) levels were significantly higher in the drug-resistant group than in the other two groups.

conclusionsThe significant differences in thiol-disulfide homeostasis and IL-10 and IFN-γ levels in the drug-resistant epilepsy group suggest that these markers indicate a poor prognosis in epilepsy.

Indexed as

BiomarkersCase-Control StudiesCross-Sectional StudiesDisulfidesDrug Resistant EpilepsyHomeostasisHumansInterferon-gammaInterleukin-10Oxidative StressProspective StudiesSulfhydryl CompoundsBiomarkersDisulfidesIFNG protein, humanIL10 protein, humanInterferon-gammaInterleukin-10Sulfhydryl CompoundsDrug-resistant epilepsyInflammationOxidative stress

Identifiers

PMID34036451
OpenAlexW3165253249

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.